C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 115 filers reported holding C4 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,842 | +428.2% | 3,141 | +681.3% | 0.00% | – |
Q2 2023 | $1,106 | -89.8% | 402 | -88.4% | 0.00% | – |
Q1 2023 | $10,855 | -83.4% | 3,457 | -68.8% | 0.00% | – |
Q4 2022 | $65,319 | +625.8% | 11,071 | +1012.7% | 0.00% | – |
Q3 2022 | $9,000 | -99.3% | 995 | -97.6% | 0.00% | -100.0% |
Q4 2021 | $1,349,000 | -48.5% | 41,897 | -28.5% | 0.00% | -40.0% |
Q3 2021 | $2,619,000 | +81.6% | 58,612 | +50.4% | 0.01% | +66.7% |
Q1 2021 | $1,442,000 | – | 38,975 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |